Medicinehospital

Edaravone

Edaravone is an intravenous treatment for amyotrophic lateral sclerosis (ALS).

Clinical information

Common uses

amyotrophic lateral sclerosis (ALS)

Common side effects

bruising (contusion)
problems walking (gait disturbance)
headache

Cautions

hypersensitivity and anaphylactic reactions have occurred
contains sodium bisulfite — may trigger allergic or asthmatic reactions

Pregnancy: animal data suggest possible fetal harm — talk to your doctor

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, edaravone injection label, setid a8245a98-2ccb-4062-b865-3aa348351b48 (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
Edaravone	Parenteral ( Injection )	1.5mg/ml - 20ml, 60mg	—	hospital